Delphinus Raises $30M Series D Round
Summary
Delphinus Medical Technologies today announced the closing of a $30 million Series D financing to fuel worldwide commercialization of its SoftVue 3D Whole Breast Ultrasound Tomography System (SoftVue). The funds closing comes on the heels of the announcement that the first SoftVue System was sold, and will go to Karmanos Cancer Institute, Detroit, where the technology was originally conceived. Delphinus Medical Technologies is a pioneering medical imaging company that has developed SoftVue, featuring the first circular array transducer technology. The patented technology is a 3D whole breast ultrasound tomography system that delivers no radiation, requires no compression, and images the entire breast with a single scan. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.